EP0647138A4 - POLYPEPTIDES AVAILABLE FROM FASCIOLA SPECIES, AND VACCINE, THERAPY PROCEDURES AND DNA SEQUENCES ENCODING THESE PEPTIDES. - Google Patents

POLYPEPTIDES AVAILABLE FROM FASCIOLA SPECIES, AND VACCINE, THERAPY PROCEDURES AND DNA SEQUENCES ENCODING THESE PEPTIDES.

Info

Publication number
EP0647138A4
EP0647138A4 EP94906095A EP94906095A EP0647138A4 EP 0647138 A4 EP0647138 A4 EP 0647138A4 EP 94906095 A EP94906095 A EP 94906095A EP 94906095 A EP94906095 A EP 94906095A EP 0647138 A4 EP0647138 A4 EP 0647138A4
Authority
EP
European Patent Office
Prior art keywords
fasciola
vaccines
species
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94906095A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP0647138A1 (en
Inventor
Andrew Richard Milner
Michel Panaccio
Terence William Spithill
Gene Louise Wijffels
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agriculture Victoria Services Pty Ltd
Original Assignee
Daratech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daratech Pty Ltd filed Critical Daratech Pty Ltd
Publication of EP0647138A1 publication Critical patent/EP0647138A1/en
Publication of EP0647138A4 publication Critical patent/EP0647138A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
EP94906095A 1993-02-05 1994-02-04 POLYPEPTIDES AVAILABLE FROM FASCIOLA SPECIES, AND VACCINE, THERAPY PROCEDURES AND DNA SEQUENCES ENCODING THESE PEPTIDES. Withdrawn EP0647138A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPL710993 1993-02-05
AUPL7109/93 1993-02-05
PCT/AU1994/000051 WO1994017820A1 (en) 1993-02-05 1994-02-04 Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same

Publications (2)

Publication Number Publication Date
EP0647138A1 EP0647138A1 (en) 1995-04-12
EP0647138A4 true EP0647138A4 (en) 1996-03-06

Family

ID=3776688

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94906095A Withdrawn EP0647138A4 (en) 1993-02-05 1994-02-04 POLYPEPTIDES AVAILABLE FROM FASCIOLA SPECIES, AND VACCINE, THERAPY PROCEDURES AND DNA SEQUENCES ENCODING THESE PEPTIDES.

Country Status (8)

Country Link
EP (1) EP0647138A4 (enExample)
JP (1) JPH07505787A (enExample)
AU (1) AU5996294A (enExample)
BR (1) BR9404004A (enExample)
CA (1) CA2126455A1 (enExample)
NO (1) NO942360L (enExample)
NZ (1) NZ261279A (enExample)
WO (1) WO1994017820A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0721466A1 (en) * 1993-09-28 1996-07-17 The University Of Melbourne Protective antigens against parasites
JP4321881B2 (ja) 1997-03-11 2009-08-26 スティヒティング ディーンスト ラントバウキュンディフ オンデルズーク 寄生虫に対する防御免疫測定法用の生体外動物もしくは攻撃モデルおよび当該方法において防御作用を示すワクチン
CA2425829A1 (en) * 2000-10-18 2002-05-16 Incyte Genomics, Inc. Proteases
HUE033623T2 (en) * 2002-09-11 2017-12-28 Genentech Inc protein purification
PL201419B1 (pl) * 2002-12-04 2009-04-30 Inst Biotechnologii I Antybiot Białko chimeryczne, sekwencja, konstrukt, komórka roślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina
PL196114B1 (pl) * 2002-12-31 2007-12-31 Inst Biotechnologii I Antybiot Ciałka inkluzyjne jako antygeny do doustnej immunizacji zwierząt
EP2485725A2 (en) * 2009-10-07 2012-08-15 Wyeth LLC Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof
ES2525106B1 (es) * 2013-06-17 2015-09-29 Universidad De Salamanca Péptido sintético derivado de Fasciola hepatica y su uso como vacuna
GB201714057D0 (en) * 2017-09-01 2017-10-18 Univ College Dublin Nat Univ Of Ireland Dublin A fasciola hepatica antigen and vaccine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0524834A2 (en) * 1991-07-25 1993-01-27 Fusanori Hamajima Immunosuppressive drugs containing a cysteine protease
WO1994009142A1 (en) * 1992-10-21 1994-04-28 Mallinckrodt Veterinary, Inc. Vaccine containing a thiol protease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8432401D0 (en) * 1984-12-21 1985-02-06 Bennett C E Liver fluke antigens
AU7871987A (en) * 1986-08-18 1988-03-08 Australian National University, The Helminth parasite vaccine
NZ232327A (en) * 1989-01-31 1993-02-25 Daratech Pty Ltd Vaccine for preventative treatment of liver fluke infection in ruminants comprising as an antigen glutathione-s-transferase (gst) of f. hepatica

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0524834A2 (en) * 1991-07-25 1993-01-27 Fusanori Hamajima Immunosuppressive drugs containing a cysteine protease
WO1994009142A1 (en) * 1992-10-21 1994-04-28 Mallinckrodt Veterinary, Inc. Vaccine containing a thiol protease

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
A.J.DOWD ET AL.: "Purification and Characterization of a cysteine Proteinase secreted from Fasciola hepatica", BIOCHEMICAL SOCIETY TRANSACTIONS, vol. 20, no. 1, UK, pages 86S *
C.CARMORA ET AL: "A Fasciola hepatica Cathepsin L proteinase prevents the adherence of eosinophils to newly excysted juvenils", BIOCHEMICAL SOCIETY TRANSACTIONS, vol. 20, no. 1, UK, pages 85S, XP001316943 *
H.YAMASAKI ET AL.: "A Cysteine Proteinase from the Liver Fluke Fasciola spp.: Purification, Characterization, Lacalization and Application to Immunodiagnosis", JPN.J.PARASITOL., vol. 38, no. 6, pages 373 - 84 *
H.YAMASAKI ET AL.: "Cloning and Sequence Analysis of the Major Cysteine Protease Expressed in the Tetramode Parasite Fasciola SP.", BIOCHEMIST,MOLECUL.BIOL.INT., vol. 31, no. 3, pages 537 - 42 *
M.-Q. KLINKERT ET AL.: "Primary structures of SM31/32 diagnostic proteins of S.mansoni and their identification as proteases", MOL.BIOCHEM.PARASITOL., vol. 33, pages 113 - 22, XP023887855, DOI: doi:10.1016/0166-6851(89)90025-X *
See also references of WO9417820A1 *

Also Published As

Publication number Publication date
NO942360L (no) 1994-10-05
EP0647138A1 (en) 1995-04-12
NZ261279A (en) 1996-03-26
CA2126455A1 (en) 1994-08-06
BR9404004A (pt) 1999-05-25
AU5996294A (en) 1994-08-29
NO942360D0 (enExample) 1994-06-21
WO1994017820A1 (en) 1994-08-18
JPH07505787A (ja) 1995-06-29

Similar Documents

Publication Publication Date Title
NO911694D0 (no) Mikroemulsjonsblanding til haarbehandling, fremgangsmaate for fremstilling og anvendelse derav.
HUP9802217A3 (en) Recombinant mva virus, and the use thereof
EP0677927A3 (en) Compression by comparison of character strings which uses a minimum number of cycles per character.
ZA972929B (en) Systems for the treatment of commingled wastes and methods for treating commingled wastes.
ZA971259B (en) Antimicrobial peptides and methods of use.
ZA200110161B (en) Anti-avB3 recombinant human antibodies, nucleic acids encoding same and methods of use.
AU6276194A (en) Use of monoterpenes, sesquiterpernes and diterpernes for the treatment of cancer
IL134480A0 (en) Kay - an immune system protein and dna sequences encoding the same
ZA93226B (en) Abrasive articles including a crosslinked siloxane, and methods of making and using same.
DE3991343D2 (en) Deformationsgeschoss, damit ausgeruestete munition, sowie verfahren zur herstellung des geschosses
HUP9902867A3 (en) Therapeutic use of vegf protein or nucleic acid coding same and implant, especially for the treatment of intimal hyperplasia
WO1995003328A3 (de) Melanom-inhibierendes protein
ZA979731B (en) Treatment of asthma.
EP0647138A4 (en) POLYPEPTIDES AVAILABLE FROM FASCIOLA SPECIES, AND VACCINE, THERAPY PROCEDURES AND DNA SEQUENCES ENCODING THESE PEPTIDES.
EP0610444A4 (en) METHOD OF TREATING VIRAL DISEASES.
NZ229679A (en) Recombinant dna sequence encoding an emeria peptide, the peptide and poultry vaccine against coccidiosis
OA09664A (en) Virus/herbicide-resistance genes, processes for the preparation thereof and the use thereof
IL98273A0 (en) Dna sequences,proteins having esterase activity coded by them,and use of such proteins
EP0586065A3 (en) Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same
HUP9904413A3 (en) Purified proteins, recombinant dna sequences and processes for controlling the ripening of coffee plants
EP0472399A3 (en) Hla-dr antigen gene, its nucleotide sequence and its use
EP0227604A3 (en) Use of oligopeptides in the treatment of viral infections
NO903801L (no) Alkalipullunase, mikroorganisme og fremgangsmaate ved fremstilling derav.
GB9421093D0 (en) Hippocampus-associated proteins, DNA sequences coding therefore and uses thereof
EP0603965A3 (en) Modified block copolymers and process for the preparation thereof.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19940906

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19960118

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19960327